About Bio-Path
Technology
Pipeline
- Pipeline
- Prexigebersen
- BP1001-A
- BP1002
- BP1003
Patients
Investors
Media
Careers
Contact Us

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery

Gagliardi M, Ashizawa AT. Biomedicines. 2021;9(4):433.

Bio-Path Holdings

All Rights Reserved

Office:

4710 Bellaire Blvd, Suite 210
Bellaire, TX 77401

T: (832) 742-1357

R&D:

5455 Dashwood Street, Suite 300
Bellaire, TX 77401

T: (832) 742-1357

About Bio-Path
Technology
Pipeline
- Pipeline
- Prexigebersen
- BP1001-A
- BP1002
- BP1003
Patients
Investors
Media
Careers
Contact Us